What's Next? Small-Cap Catalysts Coming Up This Week

We've reviewed numerous filings and press releases to highlight the catalysts for this upcoming week. Dive into our research and remember—staying ahead is key!

LGVN > The company will participate in the Emerging Growth Virtual Conference taking place February 19, 2025 3:10 – 3:20 p.m. ET.

BNRG > Nir Brenmiller, COO of Brenmiller Energy, will deliver a live presentation at the Emerging Growth Conference on Tuesday, February 18, 2025, at 10:15 AM EST

STTK > The company has announced an upcoming oral presentation at the 20th Congress of ECCO in Inflammatory Bowel Diseases 2025, taking place in Berlin, Germany, on February 20, 2025, from 6:15 PM to 6:21 PM CET. The presentation will highlight results from the IND-enabling toxicology studies of SL-325, a first-in-class DR3 blocking antibody, in non-human primates.

AEMD > The company has been invited to present at the Emerging Growth Conference on February 19, 2025. This live, interactive online event will offer existing shareholders and the investment community the chance to engage with Aethlon Medical's CEO, Mr. James Frakes, in real time.

CABA > The company will present at the 5th International Conference on Lymphocyte Engineering, taking place at the Holiday Inn Munich – City Center in Munich, Germany, on Saturday, February 22, 2025, from 10:15 AM to 10:30 AM CET. The presentation will cover safety, translational data, and clinical outcomes from the first 10 patients dosed with rese-cel across multiple ongoing clinical trials in the RESET™ clinical development program.

SMTK > The company will participate in SEMICON Korea 2025, held from February 19-21 at the COEX convention center in Seoul. CEO Ian Jenks will showcase Smartkem’s proprietary OTFT technology and be available for 1-on-1 meetings with industry professionals, media, analysts, and investors.

BMR > The company will deliver a keynote titled 'Is the Future of Video Processing Destined for GPU?' at the ACM Mile-High-Video 2025 conference in Denver, Colorado, from February 18-20, 2025. The keynote will take place on February 18, 2025, at 11:15 AM MST (1:15 PM EST).

PRZO > The company will attend IDEX UAE 2025, one of the world’s leading defense and security exhibitions. Held in Abu Dhabi from February 17-21, 2025, IDEX serves as a key platform for defense companies to connect with global military leaders.

XXII > Larry Firestone, Chief Executive Officer, will present at the Emerging Growth Conference on Wednesday, February 19, 2025, at 10:50 AM Eastern Time. He will provide an overview presentation and may open the floor for questions afterward.

LFWD > The company will host a virtual Investor Event on Thursday, February 20, 2025, starting at 10:00 AM EST. The event will include presentations and a Q&A session with the executive leadership team, covering the company's strategy, key initiatives, and financial outlook.

REVB > The company has announced the launch of its PRIME (PReconditioning IMmunostimulatory Evaluation) Phase 1b clinical study, evaluating escalating doses of intravenously administered Gemini in patients with Stage 3 and 4 Chronic Kidney Disease (CKD). The U.S.-based, multi-site, placebo-controlled study will enroll up to 40 patients across five cohorts with single escalating doses, starting in mid-February.

LUCY > The company will be a key exhibitor at Vision Expo East in Orlando, FL, from February 19-22. As the largest optical event in North America, it offers attendees the chance to explore the company's innovative smart eyewear solutions for both consumers and professionals.

OTRK > Ontrak Health will deliver its Ontrak Wholehealth+ solution, which identifies high-cost members with chronic comorbidities and untreated behavioral health conditions, offering care coaching and timely access to treatment for better outcomes and cost savings. This new agreement is expected to add approximately 2,000 members to Ontrak Health's outreach pool starting in mid-February 2025.

GNS > Genius Group is excited to sponsor the Digital Assets Institutional Investor Summit in Hong Kong on February 18, 2025, as part of Consensus, Hong Kong 2025, organized by CoinDesk. The company will engage with Asian institutional investors and funds on the growing trend of Bitcoin Treasury Companies as a way for institutions to gain exposure to Bitcoin.

SRM > The company announced that SRM will feature its creative product line at Toy Fest Vegas, taking place from February 19-21, 2025, starting Monday, February 17, 2025.

IMUX > The company will present two studies at the upcoming event: "Promising Effects of IMU-856, an Orally Available Epigenetic Modulator of Barrier Regeneration - Biomarker Findings from a Phase 1 Clinical Study" by Amelie Schreieck, Ph.D., on February 20, 2025, from 5:57-6:03 PM CET (DOP012, Session 2: Clinical Trials II) and "Preclinical Characterization of IMU-856, an Orally Available Epigenetic Modulator of Gut Barrier Function and Regeneration" by Martina Wirth, Ph.D., on February 21, 2025, from 6:27-6:33 PM CET (DOP116, Session 13: Basic Science in IBD).

OP > The company announced that, through a wholly-owned subsidiary, it has signed a Memorandum of Agreement to sell the 2005-built vessel "Salt Lake City" to a third party for US$16.1 million before commissions, with delivery to the buyer latest by February 20, 2025.

We're monitoring the following tickers for potential bounces: ICON, CISO

Watching for a potential bottom signal with some consolidation for the following tickers: KTTA, GREE (Both Have Q1 catalysts).

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.